Table 4.
Multivariate analyses of overall survival for 84 patients with TETs (II).
| Clinical factors | HR | 95%CI | P |
|---|---|---|---|
| Sex | |||
| Female | |||
| Male | 2.075 | .307-14.023 | .454 |
| Age (years) | |||
| ≤58 | |||
| >58 | 1.333 | .416-4.268 | .628 |
| Maximum tumor diameter (cm) | |||
| ≤5 | |||
| >5 | 3.629 | 1.027-12.822 | .045 |
| Surgery | 1.463 | .414-5.179 | .555 |
| Chemotherapy | 1.980 | .502-7.818 | .330 |
| Radiotherapy | 1.032 | .332-3.306 | .957 |
| WHO histological classification | 1.127 | .393-3.233 | .824 |
| Low-risk thymomas/high-risk thymomas/TCs | |||
| 8th UICC/AJCC TNM staging | 8.476 | 1.815-39.596 | .007 |
| I/II/III/IV | |||